REGENXBIO Inc.RGNXNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank8
3Y CAGR-20.5%
5Y CAGR-16.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-20.5%/yr
vs +5.4%/yr prior
5Y CAGR
-16.8%/yr
Recent deceleration
Acceleration
-26.0pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.36 | -5.1% |
| 2024 | 4.59 | -47.2% |
| 2023 | 8.70 | +0.2% |
| 2022 | 8.68 | +194.3% |
| 2021 | 2.95 | -73.0% |
| 2020 | 10.94 | -74.4% |
| 2019 | 42.66 | +507.1% |
| 2018 | 7.03 | -92.6% |
| 2017 | 95.55 | -10.5% |
| 2016 | 106.75 | - |